Scott L. Carter has been appointed to the school’s faculty and will join the department as Assistant Professor of Computational Biology. Dr. Carter also holds a faculty appointment in the Department of Biostatistics and Computational Biology at DFCI. In addition, Dr. Carter is an associate member at the Broad Institute of MIT-Harvard and a member of the joint center for cancer precision medicine at DFCI, Brigham and Women’s Hospital, and Broad Institute.
Dr. Carter holds a B.S. in Computer Science from the University of Maryland at College Park and a PhD in Bioinformatics and Integrative Genomics from the Harvard-MIT Program in Health Sciences and Technology.
Dr. Carter works closely with Boston area physicians to design and execute studies of cancer initiation, drug resistance, and metastasis using genomics technology applied to cancer-tissue specimens collected at various stages of disease progression. Dr. Carter has developed several novel computational methods in order to analyze these datasets and make inferences about clonal evolution underlying cancer progression. He has also developed software tools that are significantly increasing the impact of his work by making those methods available to the broader research community. These tools include HAPSEG, ABSOLUTE, CapSeg, Allelic CapSeg, and Phylogic. Welcome Dr. Carter!
